Bryan Hanson compensation by year
Solventum Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $1,350,000 | $1,350,000 |
| Bonus | $6,500,000 | $0 |
| Stock awards | $29,589,286 | $15,209,022 |
| Option awards | $0 | $0 |
| Non-equity incentive | $2,231,550 | $2,988,900 |
| Pension and deferred compensation | $0 | $0 |
| All other | $288,931 | $592,058 |
| Total | $39,959,767 | $20,139,981 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solventum Corp DEF 14A filed March 27, 2026, accession 0001964738-26-000017, and prior-year filings.
How this page was built: the Solventum Corp filed document, accession 0001964738-26-000017. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 506,812 | $40,159,783 | — |
| RSU | 205,892 | $16,314,882 | — |
| RSU | 191,446 | $15,170,181 | — |
| RSU | 95,723 | $7,585,091 | — |
| RSU | 67,261 | $5,456,941 | — |
| RSU | 68,631 | $5,438,320 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Solventum Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2025 proxy (filed March 27, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-01 | Tax withholding | — | 26,468 | $90.95 | 185,515 |
| 2026-09-01 | Exercise or conversion | — | 67,261 | — | 211,983 |
| 2026-09-01 | Exercise or conversion derivative | — | 67,261 | $0.00 | 0 |
| 2026-05-13 | Exercise or conversion | — | 34,315 | $0.00 | 158,225 |
| 2026-05-13 | Tax withholding | — | 13,503 | $74.41 | 144,722 |
| 2026-05-13 | Exercise or conversion derivative | — | 34,315 | $0.00 | 34,316 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Solventum’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Bryan Hanson · this page | Chief Executive Officer | $20,139,981 |
| Heather Knight | Chief Commercial Officer | $7,917,906 |
| Wayde McMillan | Chief Financial Officer | $6,165,583 |
| Christopher Barry | Former EVP and Group President, Medical Surgical | $4,232,003 |
| Marcela Kirberger | Chief Corporate & Legal Officer | $3,594,017 |
| Amy Landucci | Chief Information & Digital Officer | $3,464,975 |
Board service
Solventum board · FY2024–FY2025How this board is paid
Company policy: Solventum pays directors a $120,000 cash retainer and $225,000 in RSUs. As stated in Solventum's FY2024 proxy.
The full Solventum compensation record
free company briefThis page is one person within Solventum's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Solventum proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Solventum's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solventum's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.